Torigoe T, O-Connor R, Fagard R, Fischer S, Santoli D, Reed J C
University of Pennsylvania, Department of Pathology and Laboratory Medicine, Philadelphia.
Leukemia. 1992;6 Suppl 3:94S-97S.
Unlike many other growth factor receptors, the known subunits of the receptors for the Interleukins IL-2 and IL-3 lack intrinsic tyrosine kinase activity, and yet increases in the phosphorylation of proteins on tyrosines is a rapid event in hematolymphoid cells following stimulation with these lymphokines. Here we show that IL-2 and IL-3 regulate the activity of specific members of the SRC-family of non-receptor protein tyrosine kinases (PTKs). In IL-2-dependent T-cell lines, IL-2 induced rapid and transient increases in the activity of the p56-LCK kinase without influencing the activities of other SRC-like PTKs (p59-FYN, p62-YES) in these T-lymphocytes. In contrast to IL-2's effects on p56-LCK in T-cells, studies of an IL-2-responsive cell line of the B-cell lineage that lacks p56-LCK revealed that IL-2 specifically regulates the activity of the p53/56-LYN kinase. Thus, some flexibility exists in the ability of various SRC-like PTKs to functionally couple to IL-2 signalling pathways. In several IL-3-dependent myeloid-committed leukemic cell lines, IL-3 was found to specifically regulate the activity of the p53/56-LYN kinase without affecting the activities of other SRC-like PTKs (p59/64-HCK, p59-FYN, p62-YES) in these hematopoietic cells. This finding that p53/56-LYN can be regulated by both IL-2 in B-lineage cells and IL-3 in myeloid-committed cells demonstrates that the same SRC-family PTK can participate in signal transduction events mediated via two independent receptor systems. Taken together, our findings imply that the specific combinations of lymphokine receptors and SRC-like PTKs available for coupling with those receptors are coordinately controlled during the differentiation of hematopoietic cells.
与许多其他生长因子受体不同,白细胞介素IL-2和IL-3受体的已知亚基缺乏内在的酪氨酸激酶活性,然而在用这些淋巴因子刺激后,造血淋巴细胞中蛋白质酪氨酸磷酸化的增加却是一个快速事件。在此我们表明,IL-2和IL-3调节非受体蛋白酪氨酸激酶(PTK)的SRC家族特定成员的活性。在依赖IL-2的T细胞系中,IL-2诱导p56-LCK激酶活性快速且短暂增加,而不影响这些T淋巴细胞中其他SRC样PTK(p59-FYN、p62-YES)的活性。与IL-2对T细胞中p56-LCK的作用相反,对缺乏p56-LCK的B细胞系IL-2反应性细胞系的研究表明,IL-2特异性调节p53/56-LYN激酶的活性。因此,各种SRC样PTK在功能上与IL-2信号通路偶联的能力存在一定灵活性。在几种依赖IL-3的髓系定向白血病细胞系中,发现IL-3特异性调节p53/56-LYN激酶的活性,而不影响这些造血细胞中其他SRC样PTK(p59/64-HCK、p59-FYN、p62-YES)的活性。p53/56-LYN可在B系细胞中受IL-2调节,在髓系定向细胞中受IL-3调节,这一发现表明同一SRC家族PTK可参与经由两个独立受体系统介导的信号转导事件。综上所述,我们的发现意味着在造血细胞分化过程中,可用于与淋巴因子受体偶联的淋巴因子受体和SRC样PTK的特定组合受到协同控制。